Fotemustine plus dacarbazine for malignant melanoma
- 31 December 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (11) , 1807-1811
- https://doi.org/10.1016/0959-8049(92)90008-p
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastasesCancer, 1990
- Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefitBritish Journal of Cancer, 1990
- Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanomaCancer Chemotherapy and Pharmacology, 1990
- Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: A randomized phase II studyMedical Oncology and Tumor Pharmacotherapy, 1989
- The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanomaCancer, 1989
- The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Results with methyl-CCNU and DTIC in metastatic melanomaCancer, 1977
- Combination chemotherapy for disseminated malignant melanomaCancer, 1975
- Review of CCNU in clinical cancer therapyCancer Treatment Reviews, 1974
- Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosoureaCancer, 1972